QID 240801

Date Published: 2022-11-03

QID 240801: Red Hat Update for kernel-rt (RHSA-2022:7319)

The kernel-rt packages provide the real time linux kernel, which enables fine-tuning for systems with extremely high determinism requirements...Security Fix(es):

    posix cpu timer use-after-free may lead to local privilege escalation (cve-2022-2585).
    Unprivileged users may use ptrace_seize to set ptrace_o_suspend_seccomp option (cve-2022-30594).
Affected Products:
    Red Hat enterprise linux for real time 9 x86_64.
    Red hat enterprise linux for real time for nfv 9 x86_64.
    Red hat enterprise linux for real time for x86_64 - 4 years of updates 9.0 x86_64.
    Red hat enterprise linux for real time for nfv for x86_64 - 4 years of updates 9.0 x86_64.
.

Note: The preceding description block is extracted directly from the security advisory. Using automation, we have attempted to clean and format it as much as possible without introducing additional issues.

Successful exploitation of this vulnerability could lead to a security breach or could affect integrity, availability, and confidentiality.

  • CVSS V3 rated as High - 7.8 severity.
  • CVSS V2 rated as Medium - 4.4 severity.
    • Solution
    Refer to Red Hat security advisory RHSA-2022:7319 for updates and patch information.
    Vendor References

    CVEs related to QID 240801

    CVE-2022-2585 | CVE-2022-30594 |
    Software Advisories
    Advisory ID Software Component Link
    RHSA-2022:7319 Red Hat Enterprise Linux URL Logo access.redhat.com/errata/RHSA-2022:7319
    By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].